(1)
Riska, M.; Haryati, H.; Suhartono, E.; Wanahari, T. A. . Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated With Tyrosine Kinase Inhibitors. JR 2022, 8, 133-139.